Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Leah B Sansbury, Kieran J Rothnie, Chanchal Bains, Chris Compton, Glenn Anley & Afisi S Ismaila. (2021) Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2591-2604.
Read now
Read now
Claus F Vogelmeier, Ian P Naya, François Maltais, Leif Bjermer, Edward M Kerwin, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson & Isabelle H Boucot. (2021) Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1215-1226.
Read now
Read now
Andras Bikov, Peter Lange, Julie A Anderson, Robert D Brook, Peter M A Calverley, Bartolome R Celli, Nicholas J Cowans, Courtney Crim, Ian J Dixon, Fernando J Martinez, David E Newby, Julie C Yates & Jørgen Vestbo. (2020) FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1135-1142.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Read now
Jung-Kyu Lee, Chin Kook Rhee, Kyungjoo Kim, Seung Won Ra, Jae Ha Lee, Ki-Suck Jung, Kwang Ha Yoo, Yoo-Il Kim & Deog Kyeom Kim. (2019) Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2639-2647.
Read now
Read now
Hok Sum Chan, Fanny Wai San Ko, Johnny Wai Man Chan, Loletta Kit Ying So, David Chi Leung Lam, Veronica Lee Chan, Cheuk Yin Tam & Wai Cho Yu. (2018) Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1913-1925.
Read now
Read now
Articles from other publishers (26)
Joseph Khoa Ho, Abdollah Safari, Amin Adibi, Don D. Sin, Kate Johnson, Mohsen Sadatsafavi, Nick Bansback, Joan L. Bottorff, Stirling Bryan, Paloma Burns, Chris Carlsten, Annalijn I. Conklin, Mary De Vera, Andrea Gershon, Samir Gupta, Paul Gustafson, Stephanie Harvard, Alison M. Hoens, Mehrshad Mokhtaran, Jim Johnson, Phalgun Joshi, Janice Leung, Larry D. Lynd, Rebecca K. Metcalfe, Kristina D. Michaux, Mohsen Sadatsafavi, Brian Simmers, Don D. Sin, Daniel Smith, Laura Struik & Dhingra Vinay. (2023) Generalizability of Risk Stratification Algorithms for Exacerbations in COPD. Chest 163:4, pages 790-798.
Crossref
Crossref
Chen-Liang Tsai, Wen Pei Chang, Yen-Kuang Lin, Shu-Chuan Ho & Yu-Huei Lin. (2023) Physical frailty related to cognitive impairment and COPD exacerbation: A cross-sectional study. Respiratory Medicine 208, pages 107129.
Crossref
Crossref
Sy Duong-Quy, Thu Vo-Pham-Minh, Van Duong-Thi-Thanh, Timothy Craig & Vinh Nguyen-Nhu. (2023) Clinical Approaches to Minimize Readmissions of Patients with COPD: A
Narrative Review. Current Respiratory Medicine Reviews 19:1, pages 12-23.
Crossref
Crossref
David M.G. Halpin & Fernando J. Martinez. (2022) Pharmacotherapy and Mortality in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 206:10, pages 1201-1207.
Crossref
Crossref
John R. Hurst, MeiLan K. Han, Barinder Singh, Sakshi Sharma, Gagandeep Kaur, Enrico de Nigris, Ulf Holmgren & Mohd Kashif Siddiqui. (2022) Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respiratory Research 23:1.
Crossref
Crossref
Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen, Kristina Laugesen, Florian Voss, Jaume Aguado, Ulrich Bothner, Kenneth J. Rothman, Kristina Zint, Daniel Mines & Vera Ehrenstein. (2022) Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists. Pharmacoepidemiology and Drug Safety 31:8, pages 827-839.
Crossref
Crossref
Peter M. A. Calverley, Fernando J. Martinez, Jørgen Vestbo, Christine R. Jenkins, Robert Wise, David A. Lipson, Nicholas J. Cowans, Julie Yates, Courtney Crim & Bartolome R. Celli. (2022) International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials. American Journal of Respiratory and Critical Care Medicine 206:1, pages 25-33.
Crossref
Crossref
Sun Hye Shin, Deog Kyeom Kim, Sang-Heon Kim, Tae Rim Shin, Ki-Suck Jung, Kwang Ha Yoo, Ki-Eun Hwang, Hye Yun Park & Yong Suk Jo. (2022) Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease. Journal of Personalized Medicine 12:6, pages 916.
Crossref
Crossref
Nirupama Putcha, Antonio R. Anzueto, Peter M. A. Calverley, Bartolomé R. CelliDonald P. Tashkin, Norbert Metzdorf, Achim Mueller & Robert A. Wise. (2022) Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT. Annals of the American Thoracic Society 19:2, pages 204-213.
Crossref
Crossref
Myriam Calle Rubio, Juan Luis Rodriguez Hermosa, Juan P. de Torres, José María Marín, Cristina Martínez-González, Antonia Fuster, Borja G. Cosío, Germán Peces-Barba, Ingrid Solanes, Nuria Feu-Collado, Jose Luis Lopez-Campos & Ciro Casanova. (2021) COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort. Respiratory Research 22:1.
Crossref
Crossref
Margaret C Smith, Helen Frances Ashdown, James Peter Sheppard, Christopher C Butler & Clare Bankhead. (2021) Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink. BMJ Open 11:12, pages e050757.
Crossref
Crossref
Kian-Chung Ong. (2021) Evaluating dyspnoea in chronic obstructive pulmonary disease. Precision and Future Medicine 5:2, pages 62-68.
Crossref
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021)
Future concepts in bronchodilation for COPD: dual-
versus
monotherapy
. European Respiratory Review 30:160, pages 210023.
Crossref
Crossref
Peter Calverley. (2021) Reigniting the TORCH: Chronic Obstructive Pulmonary Disease Mortality and Inhaled Corticosteroids Revisited. American Journal of Respiratory and Critical Care Medicine 203:5, pages 531-532.
Crossref
Crossref
Dave Singh, Jadwiga A. Wedzicha, Salman Siddiqui, Alberto de la Hoz, Wenqiong Xue, Helgo Magnussen, Marc Miravitlles, James D. Chalmers & Peter M. A. Calverley. (2020) Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Respiratory Research 21:1.
Crossref
Crossref
Agnieszka Król, Robert Palmér, Virginie Rondeau, Stephen Rennard, Ulf G. Eriksson & Alexandra Jauhiainen. (2020) Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials. Respiratory Research 21:1.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2020) Tiotropium in chronic obstructive pulmonary disease – a review of clinical development. Respiratory Research 21:1.
Crossref
Crossref
Peter Calverley. (2020) Angels Dancing on the Tip of a Needle: Interpreting Clinical Trials in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 202:9, pages 1206-1207.
Crossref
Crossref
Claus F. Vogelmeier & Peter Alter. (2020) Assessing Symptom Burden. Clinics in Chest Medicine 41:3, pages 367-373.
Crossref
Crossref
Ili Margalit, Elad Goldberg, Yaara Ben Ari, Haim Ben-Zvi, Yael Shostak, Ilan Krause & Khitam Muhsen. (2020) Clinical correlates of nocardiosis. Scientific Reports 10:1.
Crossref
Crossref
Sun Hye Shin, Noeul Kang, Juhee Cho, Yeonseok Choi, Hyun Kyu Cho, Hye Sook Choi, Hojoong Kim, Jun Hyeok Lim & Hye Yun Park. (2020) Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience. Journal of Clinical Medicine 9:8, pages 2547.
Crossref
Crossref
David A. Lipson, Courtney Crim, Gerard J. Criner, Nicola C. Day, Mark T. Dransfield, David M. G. Halpin, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lomas, Sally Lettis, Pamela Manchester, Neil Martin, Dawn Midwinter, Andrea Morris, Steven J. Pascoe, Dave Singh, Robert A. Wise & Fernando J. Martinez. (2020) Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 201:12, pages 1508-1516.
Crossref
Crossref
Stanca‐Patricia Hogea, Emanuela Tudorache, Ariadna Petronela Fildan, Ovidiu Fira‐Mladinescu, Monica Marc & Cristian Oancea. (2020) Risk factors of chronic obstructive pulmonary disease exacerbations. The Clinical Respiratory Journal 14:3, pages 183-197.
Crossref
Crossref
Jessie Beaulieu, Dennis Jensen, Denis E. O’Donnell, Cynthia Brouillard, Lauren Tracey, Sandra Vincent, Éric Nadreau, Emmanuelle Bernard, Sarah Bernard & François Maltais. (2020)
Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium
versus
tiotropium: the RED trial
. Therapeutic Advances in Respiratory Disease 14, pages 175346662093950.
Crossref
Crossref
Jørgen Vestbo, Mark Dransfield, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Nicholas J. Cowans, Courtney Crim, Fernando Martinez, David E. Newby, Julie Yates & Peter Lange. (2019) Impact of pre-enrolment medication use on clinical outcomes in SUMMIT. ERJ Open Research 5:1, pages 00203-2018.
Crossref
Crossref
Peter M A Calverley, Antonio R Anzueto, Kerstine Carter, Lars Grönke, Christoph Hallmann, Christine Jenkins, Jadwiga Wedzicha & Klaus F Rabe. (2018) Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. The Lancet Respiratory Medicine 6:5, pages 337-344.
Crossref
Crossref